With more than 95% of the world’s customers living outside of the United States, it is essential that the U.S. government open new markets by advancing trade agreements with strong intellectual property (IP) provisions.


Global Innovation Policy Center @globalIPcenter 2h

“Waiving drug companies' intellectual property rights risks setting a bad precedent for future investment in new drugs. And that risk may not be worth it without additional steps to meaningfully increase the availability of shots across the world.”

Reply Retweet Favorite

Subscribe for updates from GIPC